The Effectiveness and Value of Siponimod for Secondary Progressive Multiple Sclerosis: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council

Detalles Bibliográficos
Autores principales: Synnott, Patricia G., Bloudek, Lisa M., Sharaf, Ravi, Carlson, Josh J., Pearson, Steven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476233/
https://www.ncbi.nlm.nih.gov/pubmed/32105176
http://dx.doi.org/10.18553/jmcp.2020.26.3.236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476233/
https://www.ncbi.nlm.nih.gov/pubmed/32105176
http://dx.doi.org/10.18553/jmcp.2020.26.3.236

Ejemplares similares